Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05377073
What this trial is testing

Effects of Complementary Therapies in People With Mild to Moderate Parkinson's Disease

Who this might be right for
Parkinson Disease
University of the Basque Country (UPV/EHU) 24
Not applicableUnknownNCT05312203
What this trial is testing

Alleviating Stress by Mobile Application' for Depression

Who this might be right for
Major Depressive Disorder
Korea University Guro Hospital 42
Early research (Phase 1)Study completedNCT00275080
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Post-approval studies (Phase 4)Study completedNCT01093469
What this trial is testing

Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Wake Forest University Health Sciences 39
Post-approval studies (Phase 4)Study completedNCT00568412
What this trial is testing

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Who this might be right for
Mild to Moderate Atopic Dermatitis
Bayer 80
Post-approval studies (Phase 4)UnknownNCT02724865
What this trial is testing

Somnodent vs Herbst in Mild and Moderate OSA Patients

Who this might be right for
Obstructive Sleep Apnea
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 140
Not applicableUnknownNCT01314807
What this trial is testing

Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!

Who this might be right for
Chronic Obstructive Pulmonary Disease
KU Leuven 200
Not applicableLooking for participantsNCT05683730
What this trial is testing

Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease

Who this might be right for
Crohn's Disease
Central Hospital, Nancy, France 174
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Large-scale testing (Phase 3)Study completedNCT00646516
What this trial is testing

Gemini Symbicort pMDI

Who this might be right for
Mild or Moderate Asthma
AstraZeneca 615
Large-scale testing (Phase 3)Study completedNCT04040192
What this trial is testing

Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 620
Post-approval studies (Phase 4)Study completedNCT01982539
What this trial is testing

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

Who this might be right for
Pain
Depomed 25
Not applicableUnknownNCT04781777
What this trial is testing

Effect of Ultrasonographic Guided Insulin Injection With Dexamethasone and Local Anesthetic Mixture in Diabetic Patients With Mild to Moderate Carpal Tunnel .

Who this might be right for
Pain Relief
Minia University 250
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT03332524
What this trial is testing

Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn

Who this might be right for
Sunburn
Sephoris Pharmaceuticals LLC 80
Post-approval studies (Phase 4)Study completedNCT02172586
What this trial is testing

Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients

Who this might be right for
Hypertension
Boehringer Ingelheim 363
Testing effectiveness (Phase 2)Study completedNCT00922441
What this trial is testing

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 92
Not applicableStudy completedNCT04481620
What this trial is testing

Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT

Who this might be right for
COVID-19
University Hospital, Bordeaux 1,329
Next Page